De Mangia A et al. Global real world evidence of sofosbuvir/verplatasvir as a simple effective regimen for the treatment of chronic hepatitis C patients: Integrated analysis of 12 clinical practice cohorts. (Abstract GS-03)
Behandeling van anale HSIL verlaagt risico anuscarcinoom
aug 2022 | HIV, Maag-darm-leveroncologie, Virale infecties